2013年 第7卷 第1期
《医学前沿（英文）》 >> 2013年 第7卷 第1期 doi: 10.1007/s11684-013-0254-6
FGF23 associated bone diseases
Institute of Metabolism and Endocrinology, the Second Xiangya Hospital, Central South University, Changsha 410011, China
下一篇 上一篇
摘要
Recently, fibroblast growth factor 23 (FGF23) has sparked widespread interest because of its potential role in regulating phosphate and vitamin D metabolism. In this review, we summarized the FGF superfamily, the mechanism of FGF23 on phosphate and vitamin D metabolism, and the FGF23 related bone disease.
京公网安备 11010502051620号
